
    
      This double-blind placebo-controlled pilot trial study is designed to assess the efficacy of
      12 weeks of escitalopram vs. placebo in the treatment of specific phobia in adult
      outpatients. It is hypothesized that escitalopram is safe and effective in the treatment of
      specific phobia.
    
  